Tyring, Stephen

Secukinumab in plaque psoriasis—results of two phase 3 trials

Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 1,997

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet

Psoriasis: Treatment and PathogenesisSpondyloarthritis Studies and Treatments

Cited by 1,069

Recommendations for the management of herpes zoster

Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases

Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research

Cited by 869

Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study.

Reitano, M., Tyring, S., Lang, W., Thoming, C., Worm, A. ‐., Borelli, S., Chambers, L. O., Robinson, J. M., Corey, L., & the International Valaciclovir HSV Study Group (1998) · The Journal of Infectious Diseases

Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research

Cited by 209

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

Sofen, H., Bissonnette, R., Yosipovitch, G., Silverberg, J. I., Tyring, S., Loo, W. J., Zook, M., Lee, M., Zou, L., Jiang, G.-L., et al. (2023) · eClinicalMedicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 108